Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
1,216
-
Total 13F shares, excl. options
-
502,121,728
-
Shares change
-
+18,345,423
-
Total reported value, excl. options
-
$37,169,453,852
-
Value change
-
+$1,434,005,846
-
Put/Call ratio
-
46%
-
Number of buys
-
453
-
Number of sells
-
627
-
Price
-
$74.03
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2024
As of 31 Dec 2024 Edwards Lifesciences Corp - Common Stock (EW) had 1,434 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 502,121,728 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Bank of New York Mellon Corp, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Fisher Asset Management, LLC, CITADEL ADVISORS LLC, and NORGES BANK.
This table shows 1,434 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.